Persistence of Vaccine‐Derived Polioviruses among Immunodeficient Persons with Vaccine‐Associated Paralytic Poliomyelitis
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
To estimate long-term poliovaccine virus persistence among immunodeficient patients with vaccine-associated paralytic poliomyelitis (iVAPP), cases reported in the United States during 1975-1997 were reviewed, with subsequent follow-up and virological testing. Six (16.2%) of 37 subjects excreted poliovaccine viruses for > or =6 months. Partial genomic sequencing of their available poliovirus isolates showed considerable divergence from the prototype Sabin strain in all cases. Poliovirus persistence declined over time since the last oral poliovaccine dose: at 6 months, 19.4%; 1 year, 14.3%; 5 years, 4%; and 10 years, 0% (P<.05) of patients. Despite the high prevalence of poliovaccine virus persistence among patients with iVAPP, this group appears to be an unlikely source of poliovirus reintroduction in developed countries because of the rarity and high fatality rate of iVAPP and the possible spontaneous clearance of polioviruses. These results are important for developing "endgame" strategies for the Global Poliomyelitis Eradication Program.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent reports describing highly divergent VDPVs associated with chronic poliovirus infections (10, 69, 88, 90, 113, 123, 216, 223) or with polio outbreaks (84, 169, 177, 226) underscored the earlier concerns and challenged the critical assumption that OPV-derived viruses would not long persist in the community.”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [90]
In the citing paper
“iVAPP differs markedly from VAPP in immunocompetent individuals, as it is rarely associated with Sabin 3 (14% of cases) and is more frequently associated with Sabin 1 (31% of cases) and Sabin 2 (72% of cases) (some patients were infected with more than one serotype) (90).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [90]
In the citing paper
“On the other hand, persons with T-cell immunodeficiencies, including those infected with HIV, do not appear to be at an elevated risk for VAPP (74, 90, 183, 186).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [90]
In the citing paper
“Persons with primary B-cell immunodeficiencies (see below) (168) should not be given OPV because they are at a much higher ( ∼ 3000-fold) risk for VAPP (90, 186).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [90]
In the citing paper
“A much smaller proportion ( ∼ 16%) of iVAPP patients become long-term excretors of iVDPVs (90).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [90]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Self-citationChronic Enteroviral Meningoencephalitis in Agammaglobulinemic Patients
McKinney, R. E., Katz, S. L., & Wilfert, C. M. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.2.334 · Cited by 452
Treatment of Potentially Life-Threatening Enterovirus Infections with Pleconaril
Rotbart, H. A., Webster, A. D., & for the Pleconaril Treatment Registry Group (2001) · Clinical Infectious Diseases · doi:10.1086/318452 · Cited by 373
Fine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2893-2899.1998 · Cited by 213
Self-citationKilpatrick, D. R., Nottay, B., Yang, C. F., Yang, S. J., Mulders, M. N., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2990-2996.1996 · Cited by 172
Self-citation(2000) · PsycEXTRA Dataset · doi:10.1037/e548082006-001 · Cited by 163
Self-citationChronic progressive poliomyelitis secondary to vaccination of an immunodeficient child
Davis, L. E., Bodian, D., Price, D., Butler, I. J., & Vickers, J. H. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708042970503 · Cited by 155
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction
Yang, C.-F., De, L., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1991) · Virus Research · doi:10.1016/0168-1702(91)90107-7 · Cited by 144
Self-citationPleconaril: a novel antipicornaviral drug
Romero, J. R. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.369 · Cited by 131
Cited by
Items 101–115 of 115
Enteroviruses Associated with Acute Flaccid Paralysis
Laxmivandana, R., Cherian, S., & Chitambar, S. D. (2024) · Springer eBooks · doi:10.1007/978-981-97-4480-0_8 · Cited by 1
Compliance of Caregivers with Polio Vaccine Dosages and Timelines in Lagos State, Nigeria
Salako Smith, G. (2017) · ScholarWorks (Walden University) · Cited by 1
Pavlov, D. N. (2004) · UpSpace Institutional Repository (University of Pretoria)
Gunasena, S., SILVA, R. D., Ratnayake, D., Kumarasiri, C., & Deshpande, J. M. (2014) · Sri Lankan Journal of Infectious Diseases · doi:10.4038/sljid.v4i2.6672
Quantitative analysis of trade-offs and model input sensitivities in public health
Tebbens, R. J. D. (2005)
Mane, S. S., Gupta, A., & Sharma, V. (2016) · Pediatric Infectious Disease · doi:10.1016/j.pid.2016.07.006
POLIO: OBSTACLES TO ERADICATION
Фесенко, А. Ю., & Позур, В. К. (2013) · Microbiology&Biotechnology · doi:10.18524/2307-4663.2013.4(24).48951
Live attenuated vaccines for patients with oral immunosuppressive agents
Kamei, K. (2021) · Japanese journal of pediatric nephrology · doi:10.3165/jjpn.rv.2021.0003
Colbère-Garapin, F., & Lipton, H. L. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch20
Dunn, J. J. (2008) · Wiley eBooks · doi:10.1128/9781555815455.ch8
Forensic Approach to Death as an Adverse Event Following Immunization
Gold, M., & Balakrishnan, M. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21441-7.00209-0
Ανασυνδυασμένα στελέχη πολιοϊών - θέσεις γενετικού ανασυνδυασμού
Paximadi, E. (2009) · doi:10.12681/eadd/17217
Mauel, C., Merten, C., & Bewermeyer, H. (1998) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/bf03045039
Quantitative analysis of trade-offs and model input sensitivities in public health
Tebbens, R. J. D. (2005) · Research Repository (Delft University of Technology)
Identification de virus impliqués dans les pathologies inexpliquées du patient immunodéprimé
Fourgeaud, J. (2023) · theses.fr (ABES) · doi:10.70675/14d7d370zff9bz4cc8zae90z46dc37c1a5f5
Metadata
- Authors
- Khetsuriani, N., Prevots, D. R., Quick, L., Elder, M. E., Pallansch, M., Kew, O., & Sutter, R. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- University of California, San Francisco (US)
- National Center for Infectious Diseases (US)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-12-15
- Volume
- 188
- Issue
- 12
- Pages
- 1845-1852
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2022472533
- Semantic Scholar
- 83fdf95068386f46d83baefa084cdf25850c5eec
- Cited by
- 110
- References
- 18
- Citations by year
- 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 4 · 2012: 7
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- vaccine-derived poliovirus, vaccine-associated paralytic poliomyelitis, immunodeficient patients, polio eradication, virological surveillance
- MeSH terms
- Feces, Female, Follow-Up Studies, Humans, Immunologic Deficiency Syndromes, Infant, Male, Poliomyelitis, Poliovirus Vaccine, Oral, Surveys and Questionnaires, Retrospective Studies, United States, Vaccination, Genetic Variation, Program Evaluation, Genome, Viral, Immunization Programs, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.